New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PT Indofarma Tbk
INAF.JK
Shape
US Flag

JKT

Unprofitable

EPS improving

Unprofitable

EPS improving

391B

Drug Manufacturers - Specialty & Generic

126.00IDR
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

83%

Quote Panel

Shape
Updated October 24, 2024
1W % 1M % 3M % 1Y -71.23 %

Key Metrics

Shape
  • Market Cap

    390.51B


  • Shares Outstanding

    3.10B


  • Share in Float

    371.73M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    126


  • Average Volume

    117884


  • Beta

    -0.049


  • Range

    126.0-725.0


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://indofarma.id


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.45x

P/S Ratio

-0.43x

P/B Ratio

-0.8

Debt/Equity

-260.8%

Net Margin

$-226.7

EPS

How INAF.JK compares to sector?

P/E Ratio

Relative Strength

Shape

INAF.JK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-16.51
vs 0.59

Q2.22

arrow
arrow

N/A

-12.75
vs -0.27

Q3.22

arrow
arrow

N/A

-29.81
vs 0.6

Q4.22

arrow
arrow

N/A

-79.17
vs -13.10

Q1.23

arrow
arrow

N/A

-19.94
vs -16.51

Q2.23

arrow
arrow

N/A

-18.89
vs -12.75

Q3.23

arrow
arrow

N/A

-23.02
vs -29.81

Q4.23

arrow
arrow

N/A

-170.78
vs -79.17

Q1.24

arrow
arrow

N/A

-17.41
vs -19.94

Q2.24

arrow
arrow

N/A

-15.49
vs -18.89

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-9%

339B  vs 373.2B

Q2.22

arrow
arrow

-51%

235B  vs 476.1B

Q3.22

arrow
arrow

-49%

330.8B  vs 648.5B

Q4.22

arrow
arrow

-83%

239.2B  vs 1404.1B

Q1.23

arrow
arrow

-50%

169.8B  vs 339B

Q2.23

arrow
arrow

-17%

194.2B  vs 235B

Q3.23

arrow
arrow

-75%

81.7B  vs 330.8B

Q4.23

arrow
arrow

-67%

77.9B  vs 239.2B

Q1.24

arrow
arrow

-74%

43.6B  vs 169.8B

Q2.24

arrow
arrow

-66%

66.1B  vs 194.2B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-28%

-0.28
vs -0.09

Q4.22

arrow
arrow

-284%

-2.84
vs -0.28

Q1.23

arrow
arrow

-252%

-2.52
vs -2.84

Q2.23

arrow
arrow

+172%

1.72
vs -2.52

Q3.23

arrow
arrow

+68%

0.68
vs 1.72

Q4.23

arrow
arrow

+66%

0.66
vs 0.68

Q1.24

arrow
arrow

+6%

0.06
vs 0.66

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News